The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

An interesting report on the Ivanhoe Newswire reports that patients at the University of Rochester Center in New York who have taken Clozapine have drastically greater rates of metabolic syndrome, which increases their chance of getting diabetes, stroke and heart diseases. Clozapine is the only product that the Food and Drug Administration approves for treatment of suicidal behavior.

Comments are closed.

Of Interest